Boston Scientific Corporation (LON: 0HOY)

London flag London · Delayed Price · Currency is GBP · Price in USD
88.62
-0.51 (-0.57%)
Dec 23, 2024, 6:01 AM BST
59.07%
Market Cap 104.27B
Revenue (ttm) 11.87B
Net Income (ttm) 1.34B
Shares Out n/a
EPS (ttm) 0.90
PE Ratio 77.95
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18
Open 88.95
Previous Close 89.13
Day's Range 88.62 - 88.96
52-Week Range 47.37 - 88.96
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Jan 31, 2025

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, c... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1979
Employees 48,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HOY
Full Company Profile

Financial Performance

In 2023, Boston Scientific's revenue was $14.24 billion, an increase of 12.29% compared to the previous year's $12.68 billion. Earnings were $1.57 billion, an increase of 144.55%.

Financial numbers in USD Financial Statements

News

Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries

On Wednesday, Boston Scientific Corporation (NYSE: BSX) revised the usage guidelines for its Polarx and Polarx FIT cryoablation balloon catheters following reports of serious injuries, including seve...

2 days ago - Benzinga

How did unclaimed bodies end up in the hands of a major biotech company?

How Boston Scientific’s Relievant Medsystems came to use the unclaimed dead offers a window into the pressing demand for human bodies.

4 days ago - NBC News

FDA classifies recall of Boston Scientific catheters as 'most serious'

The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's catheters used in a type of minimally invasive surgery as "most serious".

4 days ago - Reuters

Boston Scientific Corp (BSX) Tackles Health Inequities with "Close the Gap" Initiative

Boston Scientific Corp (BSX) Tackles Health Inequities with "Close the Gap" Initiative

12 days ago - GuruFocus

Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace

NEW YORK , Dec. 11, 2024 /PRNewswire/ -- Today's Marketplace (TMP) is proud to announce a featured interview with Boston Scientific (NYSE: BSX) Global Chief Medical Officer, Kenneth Stein, MD, and Sco...

12 days ago - PRNewsWire

Jim Cramer talks companies that joined the $100 billion club this year

'Mad Money' host Jim Cramer looks at companies that joined the $100 billion club this year.

13 days ago - CNBC Television

(BSX) - Analyzing Boston Scientific's Short Interest

Boston Scientific's (NYSE: BSX) short percent of float has fallen 14.77% since its last report. The company recently reported that it has 11.02 million shares sold short , which is 0.75% of all regul...

19 days ago - Benzinga

Insider Decision: Emily Woodworth Offloads $121K Worth Of Boston Scientific Stock

On December 2, a recent SEC filing unveiled that Emily Woodworth , SVP at Boston Scientific (NYSE: BSX) made an insider sell. What Happened: Woodworth's decision to sell 1,336 shares of Boston Scient...

19 days ago - Benzinga

The Best Large-Cap Stocks to Buy

Large-cap stocks are key additions to any well-rounded portfolio, but how do you find the best ones? We take a closer look here.

26 days ago - Kiplinger

$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today

Boston Scientific (NYSE: BSX) has outperformed the market over the past 10 years by 10.11% on an annualized basis producing an average annual return of 21.27%. Currently, Boston Scientific has a mark...

27 days ago - Benzinga

Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.

Acquisition to expand interventional oncology offerings with complementary therapy to treat liver-dominant metastases MARLBOROUGH, Mass. , Nov. 25, 2024 /PRNewswire/ -- Boston Scientific Corporation (...

4 weeks ago - PRNewsWire

Boston Scientific (BSX) Announces 2025 Compensation Plans

Boston Scientific (BSX) Announces 2025 Compensation Plans

4 weeks ago - GuruFocus

Why Is Medical Device Giant Boston Scientific Stock Trading Higher On Monday?

On Saturday, Boston Scientific Corporation BSX unveiled three-year primary endpoint results from the OPTION global clinical trial of the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device.

4 weeks ago - Benzinga

Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation MARLBOROUGH, Mass. and CHICAGO , ...

5 weeks ago - PRNewsWire

Boston Scientific Corporation (BSX) UBS Global Healthcare Conference (Transcript)

Boston Scientific Corporation (NYSE:BSX) UBS Global Healthcare Conference November 12, 2024 10:15 AM ET Company Participants Jonathan Monson - Senior Vice President, Investor Relations Nick Spadea-An...

5 weeks ago - Seeking Alpha

Boston Scientific Closes Acquisition of Axonics, Inc.

MARLBOROUGH, Mass. , Nov. 15, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology company ...

5 weeks ago - PRNewsWire

Kidney Stone Management Market Forecast Report, 2024-2032 - Cook Group, Richard Wolf, Boston Scientific, and Dornier MedTech Actively Engaged in M&As to Increase Share

Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Kidney Stone Management Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering. The global market size for kidn...

6 weeks ago - GlobeNewsWire

Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference

MARLBOROUGH, Mass. , Nov. 5, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 2024 UBS Global Healthcare Conference on Tuesday, November 12, 2024.

6 weeks ago - PRNewsWire

Boston Scientific Announces Agreement to Acquire Cortex, Inc.

Acquisition to complement electrophysiology portfolio with solution to advance the treatment of complex atrial fibrillation MARLBOROUGH, Mass. , Nov. 4, 2024 /PRNewswire/ -- Boston Scientific Corporat...

7 weeks ago - PRNewsWire

Boston Scientific Corporation (BSX) Business Update Earnings Call Transcript

Boston Scientific Corporation (NYSE:BSX) Business Update Earnings Conference Call October 30, 2024 4:00 PM ET Company Participants Jonathan Monson - Senior Vice President of Investor Relations Joseph...

7 weeks ago - Seeking Alpha

Why The Fundamentals Make Me Bullish On Boston Scientific

Medical devices maker Boston Scientific should continue to grow profitably through the next several years. Backing that bullishness is its history, good margins, pipeline, capital allocation, and more...

7 weeks ago - Seeking Alpha

Why is Boston Scientific Stock Trading Lower On Wednesday?

On Wednesday, Boston Scientific Corporation BSX released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe, symptomatic aortic s...

7 weeks ago - Benzinga

ACURATE neo2™ Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024

MARLBOROUGH, Mass. and WASHINGTON , Oct. 30, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the results of the primary endpoint of the ACURATE IDE clinical trial, which...

7 weeks ago - PRNewsWire

Boston Scientific Profit Falls Even as Demand for Its Heart Products Surges

Boston Scientific (BSX) shares fell Wednesday when the medical equipment manufacturer's third-quarter profit fell and its GAAP earnings per share (EPS) came in short of its guidance.

2 months ago - Investopedia